KR870000276A - (+)6-메톡시-α-메틸-2-나프탈렌 아세트산의 에스테르 제조방법 - Google Patents

(+)6-메톡시-α-메틸-2-나프탈렌 아세트산의 에스테르 제조방법 Download PDF

Info

Publication number
KR870000276A
KR870000276A KR1019850004511A KR850004511A KR870000276A KR 870000276 A KR870000276 A KR 870000276A KR 1019850004511 A KR1019850004511 A KR 1019850004511A KR 850004511 A KR850004511 A KR 850004511A KR 870000276 A KR870000276 A KR 870000276A
Authority
KR
South Korea
Prior art keywords
methyl
methoxy
acetic acid
tetrahydrofuran
process according
Prior art date
Application number
KR1019850004511A
Other languages
English (en)
Inventor
코르비 모라 카밀로
Original Assignee
도르. 피예르 루이기 코르비 모라
카밀로 코르비 예스. 피. 예이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 도르. 피예르 루이기 코르비 모라, 카밀로 코르비 예스. 피. 예이 filed Critical 도르. 피예르 루이기 코르비 모라
Publication of KR870000276A publication Critical patent/KR870000276A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/616Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety polycyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음.

Description

(+)6-메톡시-α-메틸-2-나프탈렌 아세트산의 에스테르 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 상온에서 산수용유기염의 존재하에서 중성용기 용매내에서 행해지는 산 클로라이드의 축합을 특징으로 하는 다음 일반식을 가진 (+)6-메톡시-α-메틸-나프탈렌-아세톡시-메틸-α,α-디메틸-3-싸이클로헥센-1-메탄올의 제조공정
  2. 제1항에 있어서, 피리딘 존재하 10-20℃에서 테트라하이드로퓨란내에서 행해지는 축합반응을 특징으로 하는 공정.
  3. 제2항에 있어서, 테트라하이드로푸란대신에 디옥산이 사용되는 것을 특징으로 하는 공정.
  4. 제2항에 있어서, 테트라하이드로퓨란대신에 무수 메틸렌클로라이드(에탄올로부터 유리된)가 사용되는 것을 특징으로 하는 공정.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019850004511A 1984-06-26 1985-06-25 (+)6-메톡시-α-메틸-2-나프탈렌 아세트산의 에스테르 제조방법 KR870000276A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT21609A/84 1984-06-26
IT21609/84A IT1176322B (it) 1984-06-26 1984-06-26 Estere dell'acido (+) 6-metossi-alfa-metil-2-naftalenacetico avnete attivita' mucosecretolitica,antinfiammatoria,analgesica,antiprietica,procedimento per la sua preparazione e sue composizioni farmaceutiche

Publications (1)

Publication Number Publication Date
KR870000276A true KR870000276A (ko) 1987-02-17

Family

ID=11184278

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850004511A KR870000276A (ko) 1984-06-26 1985-06-25 (+)6-메톡시-α-메틸-2-나프탈렌 아세트산의 에스테르 제조방법

Country Status (7)

Country Link
US (1) US4665224A (ko)
EP (1) EP0166135B1 (ko)
JP (1) JPS6118746A (ko)
KR (1) KR870000276A (ko)
AT (1) ATE43964T1 (ko)
DE (1) DE3570979D1 (ko)
IT (1) IT1176322B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912248A (en) * 1987-05-18 1990-03-27 The Procter & Gamble Company Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation
US5792886A (en) * 1997-01-08 1998-08-11 Albemarle Corporation Production of racemic 2-(6-methoxy-2-naphthyl) propionic acid of precursors thereof
US6080888A (en) * 1997-01-08 2000-06-27 Albemarle Corporation Preparation of olefinic compounds and carboxylic derivatives thereof
US6096920A (en) * 1997-01-08 2000-08-01 Albemarle Corporation Preparation of carboxylic compounds and their derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904682A (en) * 1967-01-13 1975-09-09 Syntex Corp 2-(6{40 -Methoxy-2{40 -naphthyl)acetic acid
US4048330A (en) * 1967-01-13 1977-09-13 Syntex Corporation Compositions containing 2-(6'-substituted-2'-naphthyl)acetic acid esters used for treating inflammation, pain or pyrexia
ZA701191B (en) * 1969-03-24 1971-09-29 Syntex Corp 2-(6-substituted-2'-naphthyl)acetic acid esters and process for producing same
IT1190663B (it) * 1982-01-21 1988-02-24 Ausonia Farma Srl Composto ad attivita' antiinfiammatoria,analgesica e mucoregolatrice,procedimento per la sua preparazione e relative composizioni farmaceutiche
DE3360037D1 (en) * 1982-04-15 1985-02-07 Firmenich & Cie 1(7)p-menthene-9-al and its use as a perfuming and flavouring agent

Also Published As

Publication number Publication date
EP0166135A2 (en) 1986-01-02
IT8421609A0 (it) 1984-06-26
IT1176322B (it) 1987-08-18
DE3570979D1 (en) 1989-07-20
EP0166135A3 (en) 1986-06-11
US4665224A (en) 1987-05-12
JPS6118746A (ja) 1986-01-27
EP0166135B1 (en) 1989-06-14
ATE43964T1 (de) 1989-06-15

Similar Documents

Publication Publication Date Title
KR880003966A (ko) 수크로스 유도체
KR840000463A (ko) 광학적으로 활성인 1-방향족 그룹으로 치환된-1- 알카논의 제조방법
KR870000276A (ko) (+)6-메톡시-α-메틸-2-나프탈렌 아세트산의 에스테르 제조방법
KR830006324A (ko) 루틴 데카 또는 노나(수소-황산염)나트륨염의 제조방법
KR840009059A (ko) 1,8-디하이드록시-10-아실-9-안트론류의 제조방법
KR830001948A (ko) 페니실린 설폭사이드의 제조방법
KR860008174A (ko) 항정신질환성 벤지소티아졸 s-산화물의 제조방법
KR830007693A (ko) 7-아미노 세펨 화합물을 제조하는 개량방법
KR830009077A (ko) 푸란 유도체의 제조방법
KR860000241A (ko) 살리싸이클산의 (-)캄포렌산 에스테르의 제조방법
KR840002406A (ko) 3위치가 티오메틸 복소환 그룹에 의해 치환된 신규의 세팔로스포린유도체의 제조방법세
KR830009015A (ko) 메르캅토 아실 카르니틴 에스테르류의 제조방법
KR900018032A (ko) 2,3-디클로로-5-아세틸피리딘의 제조방법
KR850007253A (ko) d,1-트랜스-소브레롤의 데오필린-7-아세트산 에스테르의 제조방법
KR850001228A (ko) (8s)-8-플루오로에리트로마이신의 제조방법
KR910000627A (ko) 메틸렌디(페닐우레탄)의 제조방법
KR840003639A (ko) 이속사졸로피리미딘 유도체의 제조방법
KR900018123A (ko) 광학적 활성인 d-2-n-펜아세틸아미노-4-메틸 포스피노부티르산의 라세미화 방법
KR880012523A (ko) 모노-또는 폴리-카르복실산의 에스테르로 부터 가용성 주석화합물을 제거하기 위한 방법
KR870004983A (ko) 아포빈캐미닉산(apovincaminic-acid)의 에틸에스테르의 제조방법
KR920002529A (ko) 3,3,4'-트리클로로카르바아닐라이드의 제조방법
JPS5481216A (en) Production acid amide
KR830002770A (ko) 6-아미노페니실란산의 보론 유도체의 제조방법
KR860007240A (ko) 카르바메이트 유도체의 제조방법
KR880000445A (ko) 7-아미노-3-알콕시메틸-3-세펨-4-카복실산 유도체의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application